Status:
COMPLETED
New Biomarkers Evaluating Ovarian Cancer
Lead Sponsor:
Fujirebio Diagnostics, Inc.
Conditions:
Adnexal Mass
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using th...
Eligibility Criteria
Inclusion
- Female, age 18 years or older
- Adnexal mass present documented by imaging
- Scheduled to undergo surgery based on a finding of adnexal mass
- Able and willing to provide Informed Consent
Exclusion
- Previous history of ovarian cancer
- Previous history of bilateral oophorectomy
- Currently known to be pregnant
- Unable to provide informed consent
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT01466049
Start Date
December 1 2011
End Date
March 1 2014
Last Update
August 5 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New Hanover Regional Medical Center
Wilmington, North Carolina, United States, 28402
2
University of Oklahoma
Oklahoma City, Oklahoma, United States, 73110